Reduced mortality associated with long-term postmenopausal estrogen therapy

OBJECTIVE: To compare all-cause and specific-cause mortality rates in women who had or had not used long-term postmenopausal estrogen replacement therapy (ERT). METHODS: We identified women who used long-term postmenopausal ERT and compared them with a sample of age-matched postmenopausal nonusers. Through linking of these subjects' medical record numbers to various data bases, we examined survivorship and cause of death among estrogen users and nonusers. The risk of death in 232 postmenopausal women who began ERT within 3 years of menopause and used it for at least 5 years was compared with that of 222 age-matched postmenopausal nonusers. In the users, the mean length of estrogen use was 17.1 years. RESULTS: Statistically significant reductions in all-cause mortality were found in users compared with nonusers. For death from any cause, the age-adjusted relative risk (RR) and associated 95% confidence interval (CI) in estrogen users was 0.54 (0.38-0.76). The reduction in all-cause mortality was largely due to reductions in coronary heart disease (RR 0.40, CI 0.16-1.02) and other cardiovascular disease (RR 0.27, CI 0.10-0.71). Overall cancer mortality was similar in the two groups (RR 0.85, CI 0.46-1.58), although estrogen users had a higher risk of death from breast cancer (RR 1.89, CI 0.43-8.36) and lower risk of death from lung cancer (RR 0.22, CI 0.04-1.15). CONCLUSION: Long-term ERT use is associated with lower all-cause mortality and confers this apparent protection primarily through reduction in cardiovascular disease.

This article has been cited by other articles:

				P. A. Newcomb, K. M. Egan, A. Trentham-Dietz, L. Titus-Ernstoff, J. A. Baron, J. M. Hampton, M. J. Stampfer, and W. C. Willett Prediagnostic Use of Hormone Therapy and Mortality After Breast Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 864 - 871. [Abstract] [Full Text] [PDF]

				G. Heiss, R. Wallace, G. L. Anderson, A. Aragaki, S. A. A. Beresford, R. Brzyski, R. T. Chlebowski, M. Gass, A. LaCroix, J. E. Manson, et al. Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin JAMA, March 5, 2008; 299(9): 1036 - 1045. [Abstract] [Full Text] [PDF]

				C. Rodriguez, H. Spencer Feigelson, A. Deka, A. V. Patel, E. J. Jacobs, M. J. Thun, and E. E. Calle Postmenopausal Hormone Therapy and Lung Cancer Risk in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 655 - 660. [Abstract] [Full Text] [PDF]

				J. A. Tice, A. Kanaya, T. Hue, S. Rubin, D. S. M. Buist, A. LaCroix, J. V. Lacey Jr, J. A. Cauley, S. Litwack, L. A. Brinton, et al. Risk Factors for Mortality in Middle-aged Women Arch Intern Med, December 11, 2006; 166(22): 2469 - 2477. [Abstract] [Full Text] [PDF]

				A. K. Ganti, A. E. Sahmoun, A. W. Panwalkar, K. K. Tendulkar, and A. Potti Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung Cancer J. Clin. Oncol., January 1, 2006; 24(1): 59 - 63. [Abstract] [Full Text] [PDF]

				M. B. Schabath, L. M. Hernandez, X. Wu, P. C. Pillow, and M. R. Spitz Dietary Phytoestrogens and Lung Cancer Risk JAMA, September 28, 2005; 294(12): 1493 - 1504. [Abstract] [Full Text] [PDF]

				O. H. Franco, H. Burger, C. E. I. Lebrun, P. H. M. Peeters, S. W. J. Lamberts, D. E. Grobbee, and Y. T. Van Der Schouw Higher Dietary Intake of Lignans Is Associated with Better Cognitive Performance in Postmenopausal Women J. Nutr., May 1, 2005; 135(5): 1190 - 1195. [Abstract] [Full Text] [PDF]

				S. Y. Honisett, L. Stojanovska, K. Sudhir, B. A. Kingwell, T. Dawood, and P. A. Komesaroff Hormone Therapy Impairs Endothelial Function in Postmenopausal Women with Type 2 Diabetes Mellitus Treated with Rosiglitazone J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4615 - 4619. [Abstract] [Full Text] [PDF]

				M. B. Schabath, X. Wu, R. Vassilopoulou-Sellin, A. A. Vaporciyan, and M. R. Spitz Hormone Replacement Therapy and Lung Cancer Risk: A Case-Control Analysis Clin. Cancer Res., January 1, 2004; 10(1): 113 - 123. [Abstract] [Full Text] [PDF]

				K. A. Moore, C. M. Mery, M. T. Jaklitsch, A. P. Estocin, R. Bueno, S. J. Swanson, D. J. Sugarbaker, and J. M. Lukanich Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer Ann. Thorac. Surg., December 1, 2003; 76(6): 1789 - 1795. [Abstract] [Full Text] [PDF]

				H. Olsson, A. Bladstrom, and C. Ingvar Are Smoking-Associated Cancers Prevented or Postponed in Women Using Hormone Replacement Therapy? Obstet. Gynecol., September 1, 2003; 102(3): 565 - 570. [Abstract] [Full Text] [PDF]

				P. Polo-Kantola, E. Rauhala, H. Helenius, R. Erkkola, K. Irjala, and O. Polo Breathing During Sleep in Menopause: A Randomized, Controlled, Crossover Trial With Estrogen Therapy Obstet. Gynecol., July 1, 2003; 102(1): 68 - 75. [Abstract] [Full Text] [PDF]

				M. Kreuzer, M. Gerken, J. Heinrich, L. Kreienbrock, and H-E. Wichmann Hormonal factors and risk of lung cancer among women? Int. J. Epidemiol., April 1, 2003; 32(2): 263 - 271. [Abstract] [Full Text] [PDF]

				F. Grodstein, T. B. Clarkson, and J. E. Manson Understanding the Divergent Data on Postmenopausal Hormone Therapy N. Engl. J. Med., February 13, 2003; 348(7): 645 - 650. [Full Text] [PDF]

				D. A. Grimes and R. A. Lobo Perspectives on the Women's Health Initiative Trial of Hormone Replacement Therapy Obstet. Gynecol., December 1, 2002; 100(6): 1344 - 1353. [Abstract] [Full Text] [PDF]

				A. H. Friedlander and L. J. Jones The Biology, Medical Management, and Podiatric Implications of Menopause J Am Podiatr Med Assoc, September 1, 2002; 92(8): 437 - 443. [Abstract] [Full Text] [PDF]

				R. N. Butler, M. Fossel, S. M. Harman, C. B. Heward, S. J. Olshansky, T. T. Perls, D. J. Rothman, S. M. Rothman, H. R. Warner, M. D. West, et al. Is There an Antiaging Medicine? J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2002; 57(9): B333 - 338. [Abstract] [Full Text] [PDF]

				H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan Postmenopausal Hormone Replacement Therapy: Scientific Review JAMA, August 21, 2002; 288(7): 872 - 881. [Abstract] [Full Text] [PDF]

				L. L. Humphrey, B. K.S. Chan, and H. C. Sox Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease Ann Intern Med, August 20, 2002; 137(4): 273 - 284. [Abstract] [Full Text] [PDF]

				A. Wakatsuki, Y. Ogawa, T. Saibara, Y. Okatani, and T. Fukaya Size and Oxidative Susceptibility of Low-Density Lipoprotein Particles in Breast Cancer Patients with Tamoxifen-Induced Fatty Liver J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3676 - 3681. [Abstract] [Full Text] [PDF]

				Y. T. van der Schouw, A. Pijpe, C. E.I. Lebrun, M. L. Bots, P. H.M. Peeters, W. A. van Staveren, S. W.J. Lamberts, and D. E. Grobbee Higher Usual Dietary Intake of Phytoestrogens Is Associated With Lower Aortic Stiffness in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1316 - 1322. [Abstract] [Full Text] [PDF]

				K. K. Han, J. M. Soares Jr, M. A. Haidar, G. R. de Lima, and E. C. Baracat Benefits of Soy Isoflavone Therapeutic Regimen on Menopausal Symptoms Obstet. Gynecol., March 1, 2002; 99(3): 389 - 394. [Abstract] [Full Text] [PDF]

				A. H. FRIEDLANDER The physiology, medical management and oral implications of menopause J Am Dent Assoc, January 1, 2002; 133(1): 73 - 81. [Abstract] [Full Text] [PDF]

				B. Hedblad, J. Merlo, J. Manjer, G. Engstrom, G. Berglund, and L. Janzon Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy Scand J Public Health, January 1, 2002; 30(1): 12 - 19. [Abstract] [PDF]

				A. Wakatsuki, Y. Okatani, N. Ikenoue, and T. Fukaya Effect of Medroxyprogesterone Acetate on Endothelium-Dependent Vasodilation in Postmenopausal Women Receiving Estrogen Circulation, October 9, 2001; 104(15): 1773 - 1778. [Abstract] [Full Text] [PDF]

				J. R. Rouleau, A. Dagnault, D. Simard, B. Lavallee, A. Belanger, A. Blouin, and J. G. Kingma Jr. Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1407 - H1412. [Abstract] [Full Text] [PDF]

				K. Worzala, R. Hiller, R. D. Sperduto, K. Mutalik, J. M. Murabito, M. Moskowitz, R. B. D'Agostino, and P. W. F. Wilson Postmenopausal Estrogen Use, Type of Menopause, and Lens Opacities: The Framingham Studies Arch Intern Med, June 11, 2001; 161(11): 1448 - 1454. [Abstract] [Full Text] [PDF]

				A. WAKATSUKI, N. IKENOUE, Y. OKATANI, K. SHINOHARA, K. WATANABE, and T. FUKAYA Lipolytic Enzyme Effect on Small Low-Density Lipoprotein Particles in Women Treated With Estrogen Obstet. Gynecol., March 1, 2001; 97(3): 333 - 337. [Abstract] [Full Text] [PDF]

				A. Wakatsuki, N. Ikenoue, Y. Okatani, and T. Fukaya Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women J. Am. Coll. Cardiol., February 1, 2001; 37(2): 425 - 430. [Abstract] [Full Text] [PDF]

				C. Rodriguez, E. E. Calle, A. V. Patel, L. M. Tatham, E. J. Jacobs, and M. J. Thun Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women Am. J. Epidemiol., January 15, 2001; 153(2): 145 - 152. [Abstract] [Full Text] [PDF]

				F. Lacy, M. T. Kailasam, D. T. O'Connor, G. W. Schmid-Schonbein, and R. J. Parmer Plasma Hydrogen Peroxide Production in Human Essential Hypertension : Role of Heredity, Gender, and Ethnicity Hypertension, November 1, 2000; 36(5): 878 - 884. [Abstract] [Full Text] [PDF]

				L. Mosca The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease Arch Intern Med, August 14, 2000; 160(15): 2263 - 2272. [Abstract] [Full Text] [PDF]

				H. Teoh, A. Quan, and R. Y.K Man Acute impairment of relaxation by low levels of testosterone in porcine coronary arteries Cardiovasc Res, March 1, 2000; 45(4): 1010 - 1018. [Abstract] [Full Text] [PDF]

				A. WAKATSUKI, N. IKENOUE, Y. OKATANI, and C. IZUMIYA Lipid Transfer Reactions and Lipid Composition of Low-Density Lipoprotein Particles in Postmenopausal Women Receiving Estrogen Obstet. Gynecol., October 1, 1999; 94(4): 492 - 497. [Abstract] [Full Text] [PDF]

				S. R. WEISS, H. ELLMAN, and M. DOLKER A Randomized Controlled Trial of Four Doses of Transdermal Estradiol for Preventing Postmenopausal Bone Loss Obstet. Gynecol., September 1, 1999; 94(3): 330 - 336. [Abstract] [Full Text] [PDF]

				J. F. KEANEY JR., D. I. SIMON, and J. E. FREEDMAN Vitamin E and vascular homeostasis: implications for atherosclerosis FASEB J, June 1, 1999; 13(9): 965 - 975. [Abstract] [Full Text]

				A. Cagnacci, L. Rovati, A. Zanni, S. Malmusi, F. Facchinetti, and A. Volpe Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1355 - H1360. [Abstract] [Full Text] [PDF]

				H. Teoh, S. W.S. Leung, and R. Y.K. Man Short-term exposure to physiological levels of 17{beta}-estradiol enhances endothelium-independent relaxation in porcine coronary artery Cardiovasc Res, April 1, 1999; 42(1): 224 - 231. [Abstract] [Full Text] [PDF]

				E. Sbarouni, Z. S. Kyriakides, and D. T. Kremastinos The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1244 - 1250. [Abstract] [Full Text] [PDF]

				J. Baron, G. B. Holzman, and J. Schulkin Attitudes of Obstetricians and Gynecologists toward Hormone Replacement Therapy Med Decis Making, October 1, 1998; 18(4): 406 - 411. [Abstract] [PDF]

				A. C. Liu, M. Lloyd, and R. Eastell Treatment of Postmenopausal Osteoporosis N. Engl. J. Med., July 16, 1998; 339(3): 202 - 203. [Full Text]

				L. Mosca, J. E. Manson, S. E. Sutherland, R. D. Langer, T. Manolio, E. Barrett-Connor, and E. Barrett-Connor Cardiovascular Disease in Women : A Statement for Healthcare Professionals From the American Heart Association Circulation, October 7, 1997; 96(7): 2468 - 2482. [Full Text]

				F. Grodstein, M. J. Stampfer, G. A. Colditz, W. C. Willett, J. E. Manson, M. Joffe, B. Rosner, C. Fuchs, S. E. Hankinson, D. J. Hunter, et al. Postmenopausal Hormone Therapy and Mortality N. Engl. J. Med., June 19, 1997; 336(25): 1769 - 1776. [Abstract] [Full Text] [PDF]

				G. T. Shwaery, J. A. Vita, and J. F. Keaney Jr Antioxidant Protection of LDL by Physiological Concentrations of 17ß-Estradiol : Requirement for Estradiol Modification Circulation, March 18, 1997; 95(6): 1378 - 1385. [Abstract] [Full Text]

				Long-Term Estrogen Therapy and Mortality Journal Watch Cardiology, March 1, 1996; 1996(301): 14 - 14. [Full Text]

				Long-Term Estrogen Therapy and Mortality Journal Watch Dermatology, February 1, 1996; 1996(201): 16 - 16. [Full Text]

				LONG-TERM ESTROGEN THERAPY AND MORTALITY Journal Watch (General), January 19, 1996; 1996(119): 2 - 2. [Full Text]

				A. Wakatsuki, Y. Okatani, N. Ikenoue, and T. Fukaya Effect of Medroxyprogesterone Acetate on Vascular Inflammatory Markers in Postmenopausal Women Receiving Estrogen Circulation, March 26, 2002; 105(12): 1436 - 1439. [Abstract] [Full Text] [PDF]